1. Home
  2. AURA vs FBYD Comparison

AURA vs FBYD Comparison

Compare AURA & FBYD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AURA
  • FBYD
  • Stock Information
  • Founded
  • AURA 2007
  • FBYD 2021
  • Country
  • AURA United States
  • FBYD United States
  • Employees
  • AURA N/A
  • FBYD N/A
  • Industry
  • AURA Biotechnology: Pharmaceutical Preparations
  • FBYD
  • Sector
  • AURA Health Care
  • FBYD
  • Exchange
  • AURA Nasdaq
  • FBYD Nasdaq
  • Market Cap
  • AURA 396.8M
  • FBYD 468.0M
  • IPO Year
  • AURA 2021
  • FBYD N/A
  • Fundamental
  • Price
  • AURA $6.04
  • FBYD $11.48
  • Analyst Decision
  • AURA Strong Buy
  • FBYD
  • Analyst Count
  • AURA 5
  • FBYD 0
  • Target Price
  • AURA $21.80
  • FBYD N/A
  • AVG Volume (30 Days)
  • AURA 302.8K
  • FBYD 36.7K
  • Earning Date
  • AURA 11-13-2025
  • FBYD 11-14-2025
  • Dividend Yield
  • AURA N/A
  • FBYD N/A
  • EPS Growth
  • AURA N/A
  • FBYD N/A
  • EPS
  • AURA N/A
  • FBYD 0.43
  • Revenue
  • AURA N/A
  • FBYD $7,688,000.00
  • Revenue This Year
  • AURA N/A
  • FBYD N/A
  • Revenue Next Year
  • AURA N/A
  • FBYD N/A
  • P/E Ratio
  • AURA N/A
  • FBYD $25.25
  • Revenue Growth
  • AURA N/A
  • FBYD 9.17
  • 52 Week Low
  • AURA $4.35
  • FBYD $3.62
  • 52 Week High
  • AURA $11.29
  • FBYD $16.35
  • Technical
  • Relative Strength Index (RSI)
  • AURA 48.89
  • FBYD 52.74
  • Support Level
  • AURA $5.62
  • FBYD $9.81
  • Resistance Level
  • AURA $6.60
  • FBYD $11.12
  • Average True Range (ATR)
  • AURA 0.36
  • FBYD 1.26
  • MACD
  • AURA 0.02
  • FBYD -0.08
  • Stochastic Oscillator
  • AURA 45.69
  • FBYD 55.39

About AURA Aura Biosciences Inc.

Aura Biosciences Inc is a clinical-stage biotechnology company developing precision immunotherapies to treat a range of solid tumors designed to preserve the function of organs afflicted with cancer. Its candidate bel-sar is in late-stage clinical development for the treatment of patients with primary choroidal melanoma, and other ocular oncology indications as well as in early-stage clinical development in bladder cancer. The Company views its operations and manages its business in one operating segment operating exclusively in the United States.

About FBYD Falcon's Beyond Global Inc.

Falcons Beyond Global Inc. is a Company that provides a full range of theme park design, master planning, and experiential technologies for customers in the entertainment and attraction industry through its Falcon's Creative Group reportable segment and develops and co-owns resort and theme park attractions through its Destinations Operations. The Company has four operating segments, Falcon's Creative Group, PDP, Falcon's Beyond Brands, and Destinations Operations, all of which are reportable segments. It earns the majority of the revenue from Falcon's Creative Group segment.

Share on Social Networks: